v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net increase/(decrease) in net assets resulting from operations $ (3,043,475) $ 452,701
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Repayments and sales of portfolio investments 22,421,838 16,850,812
Purchases of investments (6,866,513) (42,748,135)
Net change in unrealized (gains)/losses on investments 3,386,538 177,501
Net realized losses on investments 3,159,340 1,623,306
Net realized losses on extinguishment of debt 495,849 0
Net Reductions to Subordinated Structured Notes and related investment cost 228,707 561,569
Amortization of deferred financing costs 186,236 309,964
Amortization of premiums (accretion of purchase discounts) on investments, net (192,591) (308,936)
Payment-in-kind interest (157,722) (356,889)
Amortization of offering costs 111,672 427,341
Settlement of Treasury Bills (634) (199)
(Increase) Decrease in operating assets    
Due from Adviser (Note 4) (305,792) 0
Receivable for repayments of portfolio investments (146,150) (81,881)
Prepaid expenses and other assets 113,647 87,787
Interest receivable (97,447) (279,680)
Increase (Decrease) in operating liabilities    
Due to Administrator (Note 4) (200,156) 441,000
Accrued legal fees (114,190) (312,336)
Accrued expenses 94,386 (38,946)
Interest payable 73,142 (122,280)
Accrued audit fees 2,500 76,250
Payable for open trades 1,554 (81,856)
Due to Affiliates 300 0
Net cash provided by/(used in) operating activities 19,151,039 (23,322,907)
Cash flows from financing activities:    
Gross proceeds from shares sold 0 10,010,400
Distributions paid to stockholders (318,544) (378,127)
Repurchase of common stock (758,667) (1,389,069)
Borrowings under Senior Secured Revolving Credit Facility (Note 10) 3,400,000 43,600,000
Repayments under Senior Secured Revolving Credit Facility (Note 10) (48,900,000) (23,600,000)
Borrowings under OZK Credit Facility (Note 10) 52,775,000 0
Repayments under OZK Credit Facility (Note 10) (17,596,153) 0
Financing costs paid and deferred (959,105) (19,201)
Net cash provided by/(used in) financing activities (12,357,469) 28,224,003
Net increase (decrease) in Cash and Cash Equivalents 6,793,570 4,901,096
Cash and Cash Equivalents at beginning of period 16,499,200 15,406,421
Cash and Cash Equivalents at end of period 23,292,770 20,307,517
Supplemental disclosures:    
Cash paid for interest 1,874,043 2,592,679
Non-cash financing activities:    
Value of shares issued through reinvestment of distributions $ 2,436,429 $ 2,112,221